Inhibitor Therapeutics (INTI) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free INTI Stock Alerts $0.09 0.00 (0.00%) (As of 05/16/2024 09:02 PM ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Inhibitor Therapeutics Short Interest DataCurrent Short Volume2,300 sharesPrevious Short Volume2,300 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$197.80Short Interest Ratio / Days to Cover1.8Last Record DateApril 30, 2024Outstanding Shares172,270,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume16,200 sharesAverage Trading Volume14,440 sharesToday's Volume Vs. Average112% Short Selling Inhibitor Therapeutics ? Sign up to receive the latest short interest report for Inhibitor Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINTI Short Interest Over TimeINTI Days to Cover Over TimeINTI Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Inhibitor Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,300 shares $197.80 No ChangeN/A1.8 $0.09 4/15/20242,300 shares $178.25 +360.0%N/A0.5 $0.08 3/31/2024500 shares $35.00 +400.0%N/A0 $0.07 3/15/2024100 shares $7.70 -99.6%N/A0 $0.08 2/29/202424,800 shares $1,984.00 No ChangeN/A0.5 $0.08 11/30/2023100 shares $9.05 -94.1%N/A0 $0.09 Get the Latest News and Ratings for INTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/20231,700 shares $204.00 +1,600.0%N/A0.1 $0.12 10/31/2023100 shares $5.15 -98.2%N/A0 $0.05 10/15/20235,600 shares $268.80 No ChangeN/A1 $0.05 9/30/20235,600 shares $302.40 -73.1%N/A0.4 $0.05 9/15/202320,800 shares $1,123.20 No ChangeN/A0.3 $0.05 8/15/20232,400 shares $49.92 No ChangeN/A0 $0.02 5/31/20231,500 shares $48.00 -25.0%N/A0.2 $0.03 5/15/20232,000 shares $78.00 No ChangeN/A0.1 $0.04 11/15/20223,300 shares $198.00 +37.5%N/A0.1 $0.06 10/31/20222,400 shares $117.12 No ChangeN/A3 $0.05 10/15/20222,400 shares $105.48 No ChangeN/A4.8 $0.04 9/30/20222,400 shares $123.60 +118.2%N/A0.2 $0.05 9/15/20221,100 shares $97.68 No ChangeN/A0 $0.09 8/31/20221,100 shares $97.68 No ChangeN/A0 $0.09 4/30/2022100 shares $14.38 No ChangeN/A0.3 $0.14 4/15/2022100 shares $14.39 -50.0%N/A0 $0.14 3/31/2022200 shares $26.10 No ChangeN/A0.3 $0.13 3/15/2022200 shares $31.56 No ChangeN/A2 $0.16 2/28/2022200 shares $31.56 No ChangeN/A0.7 $0.16 2/15/2022200 shares $26.07 No ChangeN/A0.1 $0.13 1/31/2022200 shares $26.11 No ChangeN/A0.1 $0.13 11/15/20212,000 shares $318.60 No ChangeN/A0.1 $0.16 10/15/20213,000 shares $480.00 No ChangeN/A0.1 $0.16 9/30/20213,000 shares $450.90 +500.0%N/A0.3 $0.15 9/15/2021500 shares $61.05 -16.7%N/A0.5 $0.12 8/31/2021600 shares $79.80 No ChangeN/A0 $0.13 8/13/2021600 shares $120.18 No ChangeN/A0 $0.20 7/30/2021600 shares $144.00 -79.3%N/A0.1 $0.24 7/15/20212,900 shares $697.45 +26.1%N/A0.8 $0.24 6/30/20212,300 shares $553.38 +2,200.0%N/A0 $0.24 6/15/2021100 shares $12.00 -88.9%N/A0 $0.12 5/28/2021900 shares $71.01 -10.0%N/A0.1 $0.08 5/14/20211,000 shares $75.20 +900.0%N/A0.1 $0.08 4/30/2021100 shares $6.50 -98.4%N/A0 $0.07Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… INTI Short Interest - Frequently Asked Questions What is Inhibitor Therapeutics' current short interest? Short interest is the volume of Inhibitor Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,300 shares of INTI short. Learn More on Inhibitor Therapeutics' current short interest. What is a good short interest ratio for Inhibitor Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INTI shares currently have a short interest ratio of 2.0. Learn More on Inhibitor Therapeutics's short interest ratio. How does Inhibitor Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Inhibitor Therapeutics: GlycoMimetics, Inc. (9.45%), KALA BIO, Inc. (0.36%), BioVie Inc. (3.18%), Alaunos Therapeutics, Inc. (9.57%), MEI Pharma, Inc. (0.37%), Sol-Gel Technologies Ltd. (0.04%), Galecto, Inc. (0.42%), Flora Growth Corp. (1.40%), Benitec Biopharma Inc. (6.27%), NeuroBo Pharmaceuticals, Inc. (2.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Inhibitor Therapeutics stock? Short selling INTI is an investing strategy that aims to generate trading profit from Inhibitor Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inhibitor Therapeutics? A short squeeze for Inhibitor Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INTI, which in turn drives the price of the stock up even further. How often is Inhibitor Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INTI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GLYC Short Interest KALA Short Interest BIVI Short Interest TCRT Short Interest MEIP Short Interest SLGL Short Interest GLTO Short Interest FLGC Short Interest BNTC Short Interest NRBO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INTI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders